Neuropediatrics 2020; 51(03): 211-214
DOI: 10.1055/s-0039-3400975
Short Communication
Georg Thieme Verlag KG Stuttgart · New York

Cerebral Insufficiency Caused by Diazoxide in a Premature Neonate with Congenital Hyperinsulinism

Seigo Okada*
1   Department of Pediatrics, Saiseikai Shimonoseki General Hospital, Shimonoseki, Yamaguchi, Japan
2   Department of Pediatrics, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan
,
Shinnosuke Fukunaga*
1   Department of Pediatrics, Saiseikai Shimonoseki General Hospital, Shimonoseki, Yamaguchi, Japan
,
Haruka Ohta
1   Department of Pediatrics, Saiseikai Shimonoseki General Hospital, Shimonoseki, Yamaguchi, Japan
,
Takashi Furuta
1   Department of Pediatrics, Saiseikai Shimonoseki General Hospital, Shimonoseki, Yamaguchi, Japan
2   Department of Pediatrics, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan
,
Reiji Hirano
1   Department of Pediatrics, Saiseikai Shimonoseki General Hospital, Shimonoseki, Yamaguchi, Japan
,
Takahiro Motonaga
1   Department of Pediatrics, Saiseikai Shimonoseki General Hospital, Shimonoseki, Yamaguchi, Japan
,
Yuichi Ishikawa
1   Department of Pediatrics, Saiseikai Shimonoseki General Hospital, Shimonoseki, Yamaguchi, Japan
› Author Affiliations
Further Information

Publication History

14 July 2019

06 October 2019

Publication Date:
27 November 2019 (online)

Abstract

Diazoxide is a peripheral vasodilator that has been used for intravenous treatment of hypertensive emergencies. However, it is currently used mainly for hyperinsulinemic hypoglycemia in lower dose orally, and its major side effects are edema and pulmonary hypertension. Herein, we report the first association between periventricular leukomalacia (PVL) and intractable hypotension due to diazoxide. A Japanese female premature infant showed hypoglycemia concomitant with hyperinsulinemia. She was diagnosed with congenital hyperinsulinism, and oral diazoxide was started. Six days after starting diazoxide, she suddenly showed peripheral coldness, oliguria, and severe hypotension. The hypotension was refractory to general vasopressor therapies and persisted even after the discontinuation of diazoxide. Cranial echography showed periventricular echodensities followed by cystic PVL. Low-dose vasopressin effectively treated the hypotension. This single case reminds us the serious adverse events of diazoxide that have been forgotten, especially in premature neonates.

* S. Okada and S. Fukunaga contributed equally to this study.


Financial Support

This research received no specific grant from any funding agency, commercial, or not-for-profit sectors.


Authors' Contribution

S.O. led conceptualization and design of the analysis, analyzed and interpreted data, and drafted the initial manuscript. S.F. led conceptualization and design of the analysis, analyzed and interpreted data, supervised data collection, reviewed the manuscript critically, and approved the final manuscript as submitted. H.O., T.F., R.H., T.M., and Y.I. contributed to data collection and critically reviewed the manuscript.